NFKB1 and Dravet syndrome: The observed decrease in NF-κB levels in the control group and increase in T21 fibroblasts across various dosages suggest that metformin may have a context-dependent role in modulating inflammatory responses and origin from decreased expression of NF-κB among DS individuals (Salemi et al., 2015).